Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Allografting

Similar outcomes between adolescent/young adults and children with AML following allogeneic hematopoietic cell transplantation

Bone Marrow Transplantation volume 49, pages 174–178 (2014)Cite this article

Subjects

Abstract

We recently reported that adolescents and young adults (AYAs) with B-cell ALL receiving allogeneic hematopoietic cell transplantation (allo-HCT) have inferior survival compared with children, primarily because of greater TRM. We therefore hypothesized that in the setting of allo-HCT for AML, similar inferior outcomes would be observed in AYA patients as compared with children. We reviewed outcomes of 168 consecutive patients (ages 0–30 years) with AML undergoing allo-HCT at our institution. Of these, 60% (n=101) were <15 years of age and 40% (n=67) were AYAs (15–30 years of age). We identified no significant differences in 5-year overall survival (48% vs 50%, P=0.89), disease-free (47% vs 47%, P=0.89), relapse (24% vs 33%, P=0.30) or TRM (27% vs 16%, P=0.10) between the two groups. However, AYA patients had a greater incidence of grade II–IV acute (48% vs 31%, P=0.01) and chronic GVHD (22% vs 7%, P<0.01). Based on this analysis we identified no differences in survival, relapse or TRM between AYAs and children with AML receiving allo-HCT.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Woods WG . Curing childhood acute myeloid leukemia (AML) at the half-way point: promises to keep and miles to go before we sleep. Pediatr Blood Cancer 2006; 46: 565–569.

    Article  PubMed  Google Scholar 

  2. Gamis AS, Alonzo TA, Perentesis JP, Meshinchi S . Children’s Oncology Group’s 2013 blueprint for research: acute myeloid leukemia. Pediatr Blood Cancer 2013 60: 964–971.

    Article  Google Scholar 

  3. Canner JA, Alonzo TA, Franklin J, Freyer DR, Gamis AS, Gerbing RB et al. Treatment outcomes in older adolescent and young adult (AYA) patients with newly diagnosed AML. ASCO Meet Abstr 2011; 29: 9506.

    Google Scholar 

  4. Rubnitz JE, Pounds S, Cao X, Jenkins L, Dahl G, Bowman WP et al. Treatment outcome in older patients with childhood acute myeloid leukemia. Cancer 2012; 118: 6253–6259.

    Article  PubMed  Google Scholar 

  5. Bleyer A, Barr R, Hayes-Lattin B, Thomas D, Ellis C, Anderson B . The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer 2008; 8: 288–298.

    Article  CAS  PubMed  Google Scholar 

  6. Bleyer A . Young adult oncology: the patients and their survival challenges. CA Cancer J Clin 2007; 57: 242–255.

    Article  PubMed  Google Scholar 

  7. Zebrack B, Mathews-Bradshaw B, Siegel S . Quality cancer care for adolescents and young adults: a position statement. J Clin Oncol 2010; 28: 4862–4867.

    Article  PubMed  Google Scholar 

  8. Ferrari A, Montello M, Budd T, Bleyer A . The challenges of clinical trials for adolescents and young adults with cancer. Pediatr Blood Cancer 2008; 50: 1101–1104.

    Article  PubMed  Google Scholar 

  9. Majhail NS, Brazauskas R, Hassebroek A, Bredeson CN, Hahn T, Hale GA et al. Outcomes of allogeneic hematopoietic cell transplantation for adolescent and young adults compared with children and older adults with acute myeloid leukemia. Biol Blood Marrow Transplant 2012; 18: 861–873.

    Article  PubMed  Google Scholar 

  10. Burke MJ, Gossai N, Wagner JE, Smith AR, Bachanova V, Cao Q et al. Survival differences between adolescents/young adults and children with B precursor acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2013; 19: 138–142.

    Article  PubMed  Google Scholar 

  11. Bleyer A, Viny A, Barr R . Cancer in 15- to 29-year-olds by primary site. Oncologist 2006; 11: 590–601.

    Article  PubMed  Google Scholar 

  12. Bleyer WA . Cancer in older adolescents and young adults: epidemiology, diagnosis, treatment, survival, and importance of clinical trials. Med Pediatr Oncol 2002; 38: 1–10.

    Article  PubMed  Google Scholar 

  13. Scaradavou A, Brunstein CG, Eapen M, Le-Rademacher J, Barker JN, Chao N et al. Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia. Blood 2013; 121: 752–758.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Kaplan ELMP . Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481.

    Article  Google Scholar 

  15. Lin DY . Non-parametric inference for cumulative incidence functions in competing risks studies. Stat Med 1997; 16: 901–910.

    Article  CAS  PubMed  Google Scholar 

  16. Weisdorf D, Hakke R, Blazar B, Miller W, McGlave P, Ramsey N et al. Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation. Transplantation 1991; 51: 1197–1203.

    Article  CAS  PubMed  Google Scholar 

  17. MacMillan ML, Weisdorf DJ, Brunstein CG, Cao Q, DeFor TE, Verneris MR et al. Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors. Blood 2009; 113: 2410–2415.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Verneris MR, Brunstein CG, Barker J, MacMillan ML, DeFor T, McKenna DH et al. Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units. Blood 2009; 114: 4293–4299.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Eapen M, Horowitz MM, Klein JP, Champlin RE, Loberiza FR Jr, Ringden O et al. Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry. J Clin Oncol 2004; 22: 4872–4880.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The NCI CA96028 (to MJB), Children’s Cancer Research Fund (to MJB, MLM and MRV) and the University of Minnesota Pediatric Leukemia Program supported this work.

Author information

Authors and Affiliations

  1. Division of Pediatric Hematology-Oncology-BMT, Medical College of Wisconsin, Milwaukee, WI, USA

    M J Burke

  2. Department of Pediatrics, University of Minnesota Amplatz Children’s Hospital, Minneapolis, MN, USA

    N Gossai

  3. Biostatistic Core, Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA

    Q Cao

  4. Division of Pediatric Blood and Marrow Transplantation, University of Minnesota Amplatz Children’s Hospital, Minneapolis, MN, USA

    M L MacMillan & M R Verneris

  5. Division of Blood and Marrow transplantation, University of Minnesota, Minneapolis, MN, USA

    E Warlick

Authors
  1. M J Burke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N Gossai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Q Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M L MacMillan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E Warlick
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M R Verneris
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M J Burke.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Author contributions

MJB: conceived the study, reviewed data and writing of the manuscript; NG, MLM, EW and MRV: reviewed data and writing of the manuscript; QC: statistical analysis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Burke, M., Gossai, N., Cao, Q. et al. Similar outcomes between adolescent/young adults and children with AML following allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 49, 174–178 (2014). https://doi.org/10.1038/bmt.2013.171

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2013.171

Keywords

This article is cited by

Search

Advanced search

Quick links